2637 — Fujian Haixi Pharmaceuticals Co Balance Sheet
0.000.00%
Last trade - 00:00- HK$13.91bn
- HK$14.03bn
- CNY582.36m
Annual balance sheet for Fujian Haixi Pharmaceuticals Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|
| Period Length: | — | — | — | — |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | PRESS |
| Standards: | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final |
| Cash and Equivalents | ||||
| Short Term Investments | ||||
| Cash and Short Term Investments | 312 | 275 | 273 | 1,330 |
| Net Total Accounts Receivable | ||||
| Net Total Receivables | 8.04 | 25.1 | 26.7 | 53.9 |
| Total Inventory | ||||
| Prepaid Expenses | ||||
| Total Other Current Assets | ||||
| Total Current Assets | 350 | 334 | 346 | 1,440 |
| Gross Property, Plant And Equipment | ||||
| Accumulated Depreciation | ||||
| Net Property, Plant And Equipment | 45.7 | 144 | 322 | 330 |
| Net Intangible Assets | ||||
| Long Term Investments | ||||
| Long Term Notes Receivable | ||||
| Other Long Term Assets | ||||
| Total Assets | 421 | 562 | 756 | 1,847 |
| Accounts Payable | ||||
| Payable / Accrued | ||||
| Accrued Expenses | ||||
| Notes Payable / Short Term Debt | ||||
| Current Portion of Long Term Debt / Capital Leases | ||||
| Total Other Current Liabilities | ||||
| Total Current Liabilities | 90.1 | 117 | 182 | 228 |
| Long Term Debt | ||||
| Capital Lease Obligations | ||||
| Total Long Term Debt | ||||
| Total Debt | ||||
| Total Other Liabilities | ||||
| Total Liabilities | 133 | 156 | 214 | 253 |
| Common Stock | ||||
| Retained Earnings (Accumulated Deficit) | ||||
| Total Equity | 288 | 405 | 541 | 1,594 |
| Total Liabilities & Shareholders' Equity | 421 | 562 | 756 | 1,847 |
| Total Common Shares Outstanding |